TIAL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.235200E-01
Normal-vs-Stage2
4.789200E-01
Normal-vs-Stage3
1.702950E-01
Normal-vs-Stage4
4.466400E-01
Stage1-vs-Stage2
6.666000E-01
Stage1-vs-Stage3
2.888600E-01
Stage1-vs-Stage4
6.802200E-01
Stage2-vs-Stage3
1.299250E-01
Stage2-vs-Stage4
8.899800E-01
Stage3-vs-Stage4
2.630400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.676400E-01
Normal-vs-AfricanAmerican
4.962200E-01
Normal-vs-Asian
4.400000E-01
Caucasian-vs-AfricanAmerican
4.997000E-01
Caucasian-vs-Asian
7.637200E-01
AfricanAmerican-vs-Asian
5.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.870400E-01
Normal-vs-Female
4.540200E-01
Male-vs-Female
5.231800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.914400E-01
Normal-vs-Age(41-60Yrs)
5.748800E-01
Normal-vs-Age(61-80Yrs)
4.338800E-01
Normal-vs-Age(81-100Yrs)
4.179200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.144800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.096400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.734800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.212300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.033040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.230200E-01
Normal-vs-Daily Drinker
1.576960E-01
Normal-vs-Weekly Drinker
4.081000E-01
Normal-vs-Occasional Drinker
4.157000E-01
Normal-vs-Social Drinker
2.507600E-01
Non Drinker-vs-Daily Drinker
7.755200E-01
Non Drinker-vs-Weekly Drinker
8.387000E-01
Non Drinker-vs-Occasional Drinker
4.463700E-02
Non Drinker-vs-Social Drinker
3.840400E-01
Daily Drinker-vs-Weekly Drinker
6.945800E-01
Daily Drinker-vs-Occasional Drinker
1.479840E-01
Daily Drinker-vs-Social Drinker
6.154400E-01
Weekly Drinker-vs-Occasional Drinker
7.047500E-02
Weekly Drinker-vs-Social Drinker
3.789600E-01
Occasional Drinker-vs-Social Drinker
3.836800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.341780E-01
Normal-vs-Grade 2
6.056900E-03
Normal-vs-Grade 3
1.251770E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.495900E-02
Grade 1-vs-Grade 3
4.825800E-02
Grade 1-vs-Grade 4
1.341780E-01
Grade 2-vs-Grade 3
5.549200E-01
Grade 2-vs-Grade 4
6.056900E-03
Grade 3-vs-Grade 4
1.251770E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.367400E-01
Normal-vs-NonDiabetic
4.646600E-01
Diabetic-vs-NonDiabetic
6.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.043800E-01
Normal-vs-NoPancreatitis
4.454800E-01
Pancreatitis-vs-NoPancreatitis
1.510820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.140000E-01
Normal-vs-N1
4.558600E-01
N0-vs-N1
3.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.156400E-01
Normal-vs-TP53-NonMutant
1.794010E-01
TP53-Mutant-vs-TP53-NonMutant
1.142960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
